- Home
- MNDY vs NBIX Comparison
MNDY vs NBIX Comparison
Compare MNDY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDY
- NBIX
- Stock Information
- Founded
- MNDY 2012
- NBIX 1992
- Country
- MNDY Israel
- NBIX United States
- Employees
- MNDY N/A
- NBIX N/A
- Industry
- MNDY Computer Software: Prepackaged Software
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNDY Technology
- NBIX Health Care
- Exchange
- MNDY Nasdaq
- NBIX Nasdaq
- Market Cap
- MNDY 12.0B
- NBIX 11.6B
- IPO Year
- MNDY 2021
- NBIX 1996
- Fundamental
- Price
- MNDY $300.65
- NBIX $120.69
- Analyst Decision
- MNDY Strong Buy
- NBIX Buy
- Analyst Count
- MNDY 24
- NBIX 21
- Target Price
- MNDY $352.21
- NBIX $168.35
- AVG Volume (30 Days)
- MNDY 1.3M
- NBIX 1.6M
- Earning Date
- MNDY 02-10-2025
- NBIX 02-06-2025
- Dividend Yield
- MNDY N/A
- NBIX N/A
- EPS Growth
- MNDY N/A
- NBIX 33.20
- EPS
- MNDY 0.62
- NBIX 3.29
- Revenue
- MNDY $971,995,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- MNDY $27.26
- NBIX $16.29
- Revenue Next Year
- MNDY $24.17
- NBIX $16.90
- P/E Ratio
- MNDY $463.06
- NBIX $36.68
- Revenue Growth
- MNDY 33.21
- NBIX 24.81
- 52 Week Low
- MNDY $174.75
- NBIX $110.95
- 52 Week High
- MNDY $342.64
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- MNDY 58.32
- NBIX 35.76
- Support Level
- MNDY $294.50
- NBIX $113.00
- Resistance Level
- MNDY $323.72
- NBIX $118.61
- Average True Range (ATR)
- MNDY 14.62
- NBIX 4.28
- MACD
- MNDY 1.89
- NBIX -2.22
- Stochastic Oscillator
- MNDY 58.10
- NBIX 18.81
About MNDY monday.com Ltd.
Monday.com is a provider of work management software delivered via a cloud-based software-as-a-service, or SaaS model. The firm's solutions offer flexible and highly customizable tools to digitize business processes across countless use cases. Monday's offering supports workflow management across departments, real-time visibility and accountability, and automation capabilities. Monday also offers prepackaged CRM and DevOps management solutions, in addition to standalone survey and digital whiteboard tools. As of 2023, Monday served over 225,000 customers in more than 200 countries.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.